<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The function optimal_bias of the drugdevelopR package enables planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules including methods for discounting of phase II results (Preussler et. al, 2020). The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: bias) or modelled by a prior distribution. The R Shiny application prior visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming."><title>Optimal phase II/III drug development planning when discounting phase II results — optimal_bias • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.1.0/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.1.0/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.rawgit.com/afeld/bootstrap-toc/v1.0.1/dist/bootstrap-toc.min.js"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Optimal phase II/III drug development planning when discounting phase II results — optimal_bias"><meta property="og:description" content="The function optimal_bias of the drugdevelopR package enables planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules including methods for discounting of phase II results (Preussler et. al, 2020). The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: bias) or modelled by a prior distribution. The R Shiny application prior visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Optimal phase II/III drug development planning when discounting phase II results</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/optimal_bias.R" class="external-link"><code>R/optimal_bias.R</code></a></small>
      <div class="d-none name"><code>optimal_bias.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The function <code>optimal_bias</code> of the drugdevelopR package enables planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules including methods for discounting of phase II results (Preussler et. al, 2020). The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: <a href="https://web.imbi.uni-heidelberg.de/bias/" class="external-link">bias</a>) or modelled by a prior distribution. The R Shiny application <a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a> visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="fu">optimal_bias</span><span class="op">(</span>
  <span class="va">w</span>,
  <span class="va">hr1</span>,
  <span class="va">hr2</span>,
  <span class="va">id1</span>,
  <span class="va">id2</span>,
  <span class="va">d2min</span>,
  <span class="va">d2max</span>,
  <span class="va">stepd2</span>,
  <span class="va">hrgomin</span>,
  <span class="va">hrgomax</span>,
  <span class="va">stephrgo</span>,
  adj <span class="op">=</span> <span class="st">"both"</span>,
  lambdamin <span class="op">=</span> <span class="cn">NULL</span>,
  lambdamax <span class="op">=</span> <span class="cn">NULL</span>,
  steplambda <span class="op">=</span> <span class="cn">NULL</span>,
  alphaCImin <span class="op">=</span> <span class="cn">NULL</span>,
  alphaCImax <span class="op">=</span> <span class="cn">NULL</span>,
  stepalphaCI <span class="op">=</span> <span class="cn">NULL</span>,
  <span class="va">alpha</span>,
  <span class="va">beta</span>,
  <span class="va">xi2</span>,
  <span class="va">xi3</span>,
  <span class="va">c2</span>,
  <span class="va">c3</span>,
  <span class="va">c02</span>,
  <span class="va">c03</span>,
  K <span class="op">=</span> <span class="cn">Inf</span>,
  N <span class="op">=</span> <span class="cn">Inf</span>,
  S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,
  steps1 <span class="op">=</span> <span class="fl">1</span>,
  stepm1 <span class="op">=</span> <span class="fl">0.95</span>,
  stepl1 <span class="op">=</span> <span class="fl">0.85</span>,
  <span class="va">b1</span>,
  <span class="va">b2</span>,
  <span class="va">b3</span>,
  fixed <span class="op">=</span> <span class="cn">FALSE</span>,
  num_cl <span class="op">=</span> <span class="fl">1</span>
<span class="op">)</span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>w</dt>
<dd><p>weight for mixture prior distribution</p></dd>
<dt>hr1</dt>
<dd><p>first assumed true treatment effect on HR scale for prior distribution</p></dd>
<dt>hr2</dt>
<dd><p>second assumed true treatment effect on HR scale for prior distribution</p></dd>
<dt>id1</dt>
<dd><p>amount of information for hr1 in terms of number of events</p></dd>
<dt>id2</dt>
<dd><p>amount of information for hr2 in terms of number of events</p></dd>
<dt>d2min</dt>
<dd><p>minimal number of events for phase II</p></dd>
<dt>d2max</dt>
<dd><p>maximal number of events for phase II</p></dd>
<dt>stepd2</dt>
<dd><p>stepsize for the optimization over d2</p></dd>
<dt>hrgomin</dt>
<dd><p>minimal threshold value for the go/no-go decision rule</p></dd>
<dt>hrgomax</dt>
<dd><p>maximal threshold value for the go/no-go decision rule</p></dd>
<dt>stephrgo</dt>
<dd><p>stepsize for the optimization over HRgo</p></dd>
<dt>adj</dt>
<dd><p>choose type of adjustment: "multiplicative", "additive", "both" (or "all")</p></dd>
<dt>lambdamin</dt>
<dd><p>minimal adjustment parameter lambda</p></dd>
<dt>lambdamax</dt>
<dd><p>maximal adjustment parameter lambda</p></dd>
<dt>steplambda</dt>
<dd><p>stepsize for the adjustment parameter lambda</p></dd>
<dt>alphaCImin</dt>
<dd><p>minimal alphaCI</p></dd>
<dt>alphaCImax</dt>
<dd><p>maximal alphaCI</p></dd>
<dt>stepalphaCI</dt>
<dd><p>stepsize for alphaCI</p></dd>
<dt>alpha</dt>
<dd><p>one-sided significance level</p></dd>
<dt>beta</dt>
<dd><p>1-beta power for calculation of the number of events for phase III by Schoenfeld (1981) formula</p></dd>
<dt>xi2</dt>
<dd><p>event rate for phase II</p></dd>
<dt>xi3</dt>
<dd><p>event rate for phase III</p></dd>
<dt>c2</dt>
<dd><p>variable per-patient cost for phase II</p></dd>
<dt>c3</dt>
<dd><p>variable per-patient cost for phase III</p></dd>
<dt>c02</dt>
<dd><p>fixed cost for phase II</p></dd>
<dt>c03</dt>
<dd><p>fixed cost for phase III</p></dd>
<dt>K</dt>
<dd><p>constraint on the costs of the program, default: Inf, e.g. no constraint</p></dd>
<dt>N</dt>
<dd><p>constraint on the total expected sample size of the program, default: Inf, e.g., no constraint</p></dd>
<dt>S</dt>
<dd><p>constraint on the expected probability of a successful program, default: -Inf, e.g., no constraint</p></dd>
<dt>steps1</dt>
<dd><p>lower boundary for effect size category "small" in HR scale, default: 1</p></dd>
<dt>stepm1</dt>
<dd><p>lower boundary for effect size category "medium" in HR scale = upper boundary for effect size category "small" in HR scale, default: 0.95</p></dd>
<dt>stepl1</dt>
<dd><p>lower boundary for effect size category "large" in HR scale = upper boundary for effect size category "medium" in HR scale, default: 0.85</p></dd>
<dt>b1</dt>
<dd><p>expected gain for effect size category "small"</p></dd>
<dt>b2</dt>
<dd><p>expected gain for effect size category "medium"</p></dd>
<dt>b3</dt>
<dd><p>expected gain for effect size category "large"</p></dd>
<dt>fixed</dt>
<dd><p>choose if true treatment effects are fixed or random, if TRUE hr1 is used as fixed effect</p></dd>
<dt>num_cl</dt>
<dd><p>number of clusters used for parallel computing, default: 1</p></dd>
<dt>gamma</dt>
<dd><p>to model different populations in phase II and III choose gamma!=0, default: 0</p></dd>
<dt>skipII</dt>
<dd><p>choose if skipping phase II is an option, default: FASLE</p></dd>
</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>The output of the function <code>optimal_bias</code> is a data.frame containing the optimization results:</p><dl><dt>Method</dt>
<dd><p>Type of adjustment: multipl. (multiplicative) or add. (additive)</p></dd>

  <dt>u</dt>
<dd><p>maximal expected utility</p></dd>

  <dt>Adj</dt>
<dd><p>optimal adjustment parameter (lambda or alphaCI according to Method)</p></dd>

  <dt>HRgo</dt>
<dd><p>optimal threshold value for the decision rule to go to phase III</p></dd>

  <dt>d2</dt>
<dd><p>optimal total number of events for phase II</p></dd>

  <dt>d3</dt>
<dd><p>total expected number of events for phase III; rounded to next natural number</p></dd>

  <dt>d</dt>
<dd><p>total expected number of events in the program; d = d2 + d3</p></dd>

  <dt>n2</dt>
<dd><p>total sample size for phase II; rounded to the next even natural number</p></dd>

  <dt>n3</dt>
<dd><p>total sample size for phase III; rounded to the next even natural number</p></dd>

  <dt>n</dt>
<dd><p>total sample size in the program; n = n2 + n3</p></dd>

  <dt>K</dt>
<dd><p>maximal costs of the program</p></dd>

  <dt>pgo</dt>
<dd><p>probability to go to phase III</p></dd>

  <dt>sProg</dt>
<dd><p>probability of a successful program</p></dd>

  <dt>sProg1</dt>
<dd><p>probability of a successful program with "small" treatment effect in Phase III</p></dd>

  <dt>sProg2</dt>
<dd><p>probability of a successful program with "medium" treatment effect in Phase III</p></dd>

  <dt>sProg3</dt>
<dd><p>probability of a successful program with "large" treatment effect in Phase III</p></dd>

  <dt>K2</dt>
<dd><p>expected costs for phase II</p></dd>

  <dt>K3</dt>
<dd><p>expected costs for phase III</p></dd>

  
</dl><p>and further input parameters.
Taking cat(comment()) of the data.frame object lists the used optimization sequences, start and finish date of the optimization procedure.</p>
    </div>
    <div class="section level2">
    <h2 id="drugdevelopr-functions">drugdevelopR functions<a class="anchor" aria-label="anchor" href="#drugdevelopr-functions"></a></h2>
    

<p>The drugdevelopR package provides the functions</p><ul><li><p><code><a href="optimal_tte.html">optimal_tte</a></code>,</p></li>
<li><p><code><a href="optimal_binary.html">optimal_binary</a></code> and</p></li>
<li><p><code><a href="optimal_normal.html">optimal_normal</a></code></p></li>
</ul><p>to plan optimal phase II/III drug development programs with</p><ul><li><p>time-to-event (treatment effect measured by hazard ratio (HR)),</p></li>
<li><p>binary (treatment effect measured by risk ratio (RR)) or</p></li>
<li><p>normally distributed (treatment effect measured by standardized difference in means (Delta))</p></li>
</ul><p>endpoint, where the treatment effect is modelled by a <a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a>. Optimal phase II/III drug development planning with fixed treatment effects can be done with the help of the R Shiny application <a href="https://web.imbi.uni-heidelberg.de/basic/" class="external-link">basic</a>. Extensions are</p><ul><li><p>optimal planning of programs including methods for discounting of phase II results (function: <code>optimal_bias</code>, App: <a href="https://web.imbi.uni-heidelberg.de/bias/" class="external-link">bias</a>),</p></li>
<li><p>optimal planning of programs with several phase III trials (function: <code><a href="optimal_multitrial.html">optimal_multitrial</a></code>, App: <a href="https://web.imbi.uni-heidelberg.de/multitrial/" class="external-link">multitrial</a>) and</p></li>
<li><p>optimal planning of programs with multiple arms (function: <code><a href="optimal_multiarm.html">optimal_multiarm</a></code>, App: <a href="https://web.imbi.uni-heidelberg.de/multiarm/" class="external-link">multiarm</a>).</p></li>
</ul></div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>IQWiG (2016). Allgemeine Methoden. Version 5.0, 10.07.2016, Technical Report. Available at <a href="https://www.iqwig.de/de/methoden/methodenpapier.3020.html" class="external-link">https://www.iqwig.de/de/methoden/methodenpapier.3020.html</a>, assessed last 15.05.19.</p>
<p>Preussler, S., Kirchner, M., Goette, H., Kieser, M. (2020). Optimal designs for phase II/III drug development programs including methods for discounting of phase II results. Submitted to peer-review journal.</p>
<p>Schoenfeld, D. (1981). The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika, 68(1), 316-319.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span class="va">res</span> <span class="op">&lt;-</span> <span class="fu">optimal_bias</span><span class="op">(</span>w <span class="op">=</span> <span class="fl">0.3</span>,                                 <span class="co"># define parameters for prior</span></span>
<span class="r-in">  hr1 <span class="op">=</span> <span class="fl">0.69</span>, hr2 <span class="op">=</span> <span class="fl">0.88</span>, id1 <span class="op">=</span> <span class="fl">210</span>, id2 <span class="op">=</span> <span class="fl">420</span>,              <span class="co"># (https://web.imbi.uni-heidelberg.de/prior/)</span></span>
<span class="r-in">  d2min <span class="op">=</span> <span class="fl">20</span>, d2max <span class="op">=</span> <span class="fl">100</span>, stepd2 <span class="op">=</span> <span class="fl">5</span>,                       <span class="co"># define optimization set for d2</span></span>
<span class="r-in">  hrgomin <span class="op">=</span> <span class="fl">0.7</span>, hrgomax <span class="op">=</span> <span class="fl">0.9</span>, stephrgo <span class="op">=</span> <span class="fl">0.05</span>,             <span class="co"># define optimization set for HRgo</span></span>
<span class="r-in">  adj <span class="op">=</span> <span class="st">"both"</span>,                                              <span class="co"># choose type of adjustment</span></span>
<span class="r-in">  lambdamin <span class="op">=</span> <span class="fl">0.2</span>, lambdamax <span class="op">=</span> <span class="fl">1</span>, steplambda <span class="op">=</span> <span class="fl">0.05</span>,         <span class="co"># define optimization set for lambda</span></span>
<span class="r-in">  alphaCImin <span class="op">=</span> <span class="fl">0.025</span>, alphaCImax <span class="op">=</span> <span class="fl">0.5</span>, stepalphaCI <span class="op">=</span> <span class="fl">0.025</span>, <span class="co"># define optimization set for alphaCI</span></span>
<span class="r-in">  alpha <span class="op">=</span> <span class="fl">0.025</span>, beta <span class="op">=</span> <span class="fl">0.1</span>, xi2 <span class="op">=</span> <span class="fl">0.7</span>, xi3 <span class="op">=</span> <span class="fl">0.7</span>,            <span class="co"># drug development planning parameters</span></span>
<span class="r-in">  c2 <span class="op">=</span> <span class="fl">0.75</span>, c3 <span class="op">=</span> <span class="fl">1</span>, c02 <span class="op">=</span> <span class="fl">100</span>, c03 <span class="op">=</span> <span class="fl">150</span>,                   <span class="co"># define fixed and variable costs for phase II and III</span></span>
<span class="r-in">  K <span class="op">=</span> <span class="cn">Inf</span>, N <span class="op">=</span> <span class="cn">Inf</span>, S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,                                <span class="co"># set maximal costs/ expected sample size for the program or minimal expected probability of a successful program</span></span>
<span class="r-in">  steps1 <span class="op">=</span> <span class="fl">1</span>,                                                <span class="co"># define lower boundary for "small"</span></span>
<span class="r-in">  stepm1 <span class="op">=</span> <span class="fl">0.95</span>,                                             <span class="co"># "medium"</span></span>
<span class="r-in">  stepl1 <span class="op">=</span> <span class="fl">0.85</span>,                                             <span class="co"># and "large" treatment effect size categories as proposed by IQWiG (2016)</span></span>
<span class="r-in">  b1 <span class="op">=</span> <span class="fl">1000</span>, b2 <span class="op">=</span> <span class="fl">2000</span>, b3 <span class="op">=</span> <span class="fl">3000</span>,                           <span class="co"># define expected benefit for a "small", "medium" and "large" treatment effect</span></span>
<span class="r-in">  fixed <span class="op">=</span> <span class="cn">FALSE</span>,                                             <span class="co"># choose if true treatment effects are fixed or random</span></span>
<span class="r-in">  num_cl <span class="op">=</span> <span class="fl">1</span><span class="op">)</span>                                                <span class="co"># set number of cores used for parallelized computing (check maximum number possible with detectCores())</span></span>
<span class="r-err co"><span class="r-pr">#&gt;</span> <span class="error">Error in qnorm(1 - alpha):</span> object 'alpha' not found</span>
<span class="r-in"><span class="va">res</span></span>
<span class="r-err co"><span class="r-pr">#&gt;</span> <span class="error">Error in eval(expr, envir, enclos):</span> object 'res' not found</span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/base/cat.html" class="external-link">cat</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/comment.html" class="external-link">comment</a></span><span class="op">(</span><span class="va">res</span><span class="op">)</span><span class="op">)</span>                                            <span class="co"># displays the optimization sequence, start and finish date of the optimization procedure.</span></span>
<span class="r-err co"><span class="r-pr">#&gt;</span> <span class="error">Error in comment(res):</span> object 'res' not found</span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Stella Preussler.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.2.</p>
</div>

    </footer></div>

  

  

  </body></html>

